57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors

Saved in:
Bibliographic Details
Published in:ESMO open 2024-06, Vol.9, p.103564, Article 103564
Main Authors: Mosimann, F. Stella, Varano, V., Tasca, G., Girardi, F., Tozzi, R., Massa, D., Zovato, S., Saccardi, C., Moserle, L., Montagna, M., Griguolo, G., Guarneri, V.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 103564
container_title ESMO open
container_volume 9
creator Mosimann, F. Stella
Varano, V.
Tasca, G.
Girardi, F.
Tozzi, R.
Massa, D.
Zovato, S.
Saccardi, C.
Moserle, L.
Montagna, M.
Griguolo, G.
Guarneri, V.
description
doi_str_mv 10.1016/j.esmoop.2024.103564
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_esmoop_2024_103564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2059702924013334</els_id><sourcerecordid>S2059702924013334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1464-9ecda9430e88d1b5c9615358038a8be6823e27ab3f72be4603fcb579a8dcf7963</originalsourceid><addsrcrecordid>eNp9UMtqwzAQNKWFhjR_0IN-wInkty-FNPQFgZrQnoUsr5MNtmQkxdBv6c9Wxj301NMOszvDzgTBPaNrRlm2Oa_B9loP64hGiafiNEuugkVE0zLMaVRe_8G3wcraM6WU5Ykns0XwneYVqYw-Km0dSoL9IKQjuiXtRUmHWomONLoXqCby8bDbsk1E-osT05J4eug8VJc-tKAsOhyBGJAXY0A5AgO6E3ToXfQoDApFpFASDBm8yl_Y6RhwRHUk1fZQeccT1ui0sXfBTSs6C6vfuQw-n58-dq_h_v3lbbfdh5IlWRKWIBtRJjGFomhYncoyY2mcFjQuRFFDVkQxRLmo4zaPakgyGreyTvNSFI1s8zKLl0Ey-0qjrTXQ8sFgL8wXZ5RPHfMznzvmU8d87tjLHmYZ-N9GBMOt9IkkNOgjOd5o_N_gB_4fifQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors</title><source>ScienceDirect®</source><source>PubMed Central</source><creator>Mosimann, F. Stella ; Varano, V. ; Tasca, G. ; Girardi, F. ; Tozzi, R. ; Massa, D. ; Zovato, S. ; Saccardi, C. ; Moserle, L. ; Montagna, M. ; Griguolo, G. ; Guarneri, V.</creator><creatorcontrib>Mosimann, F. Stella ; Varano, V. ; Tasca, G. ; Girardi, F. ; Tozzi, R. ; Massa, D. ; Zovato, S. ; Saccardi, C. ; Moserle, L. ; Montagna, M. ; Griguolo, G. ; Guarneri, V.</creatorcontrib><identifier>ISSN: 2059-7029</identifier><identifier>EISSN: 2059-7029</identifier><identifier>DOI: 10.1016/j.esmoop.2024.103564</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>ESMO open, 2024-06, Vol.9, p.103564, Article 103564</ispartof><rights>2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2059702924013334$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,27905,27906,45761</link.rule.ids></links><search><creatorcontrib>Mosimann, F. Stella</creatorcontrib><creatorcontrib>Varano, V.</creatorcontrib><creatorcontrib>Tasca, G.</creatorcontrib><creatorcontrib>Girardi, F.</creatorcontrib><creatorcontrib>Tozzi, R.</creatorcontrib><creatorcontrib>Massa, D.</creatorcontrib><creatorcontrib>Zovato, S.</creatorcontrib><creatorcontrib>Saccardi, C.</creatorcontrib><creatorcontrib>Moserle, L.</creatorcontrib><creatorcontrib>Montagna, M.</creatorcontrib><creatorcontrib>Griguolo, G.</creatorcontrib><creatorcontrib>Guarneri, V.</creatorcontrib><title>57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors</title><title>ESMO open</title><issn>2059-7029</issn><issn>2059-7029</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UMtqwzAQNKWFhjR_0IN-wInkty-FNPQFgZrQnoUsr5MNtmQkxdBv6c9Wxj301NMOszvDzgTBPaNrRlm2Oa_B9loP64hGiafiNEuugkVE0zLMaVRe_8G3wcraM6WU5Ykns0XwneYVqYw-Km0dSoL9IKQjuiXtRUmHWomONLoXqCby8bDbsk1E-osT05J4eug8VJc-tKAsOhyBGJAXY0A5AgO6E3ToXfQoDApFpFASDBm8yl_Y6RhwRHUk1fZQeccT1ui0sXfBTSs6C6vfuQw-n58-dq_h_v3lbbfdh5IlWRKWIBtRJjGFomhYncoyY2mcFjQuRFFDVkQxRLmo4zaPakgyGreyTvNSFI1s8zKLl0Ey-0qjrTXQ8sFgL8wXZ5RPHfMznzvmU8d87tjLHmYZ-N9GBMOt9IkkNOgjOd5o_N_gB_4fifQ</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Mosimann, F. Stella</creator><creator>Varano, V.</creator><creator>Tasca, G.</creator><creator>Girardi, F.</creator><creator>Tozzi, R.</creator><creator>Massa, D.</creator><creator>Zovato, S.</creator><creator>Saccardi, C.</creator><creator>Moserle, L.</creator><creator>Montagna, M.</creator><creator>Griguolo, G.</creator><creator>Guarneri, V.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202406</creationdate><title>57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors</title><author>Mosimann, F. Stella ; Varano, V. ; Tasca, G. ; Girardi, F. ; Tozzi, R. ; Massa, D. ; Zovato, S. ; Saccardi, C. ; Moserle, L. ; Montagna, M. ; Griguolo, G. ; Guarneri, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1464-9ecda9430e88d1b5c9615358038a8be6823e27ab3f72be4603fcb579a8dcf7963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mosimann, F. Stella</creatorcontrib><creatorcontrib>Varano, V.</creatorcontrib><creatorcontrib>Tasca, G.</creatorcontrib><creatorcontrib>Girardi, F.</creatorcontrib><creatorcontrib>Tozzi, R.</creatorcontrib><creatorcontrib>Massa, D.</creatorcontrib><creatorcontrib>Zovato, S.</creatorcontrib><creatorcontrib>Saccardi, C.</creatorcontrib><creatorcontrib>Moserle, L.</creatorcontrib><creatorcontrib>Montagna, M.</creatorcontrib><creatorcontrib>Griguolo, G.</creatorcontrib><creatorcontrib>Guarneri, V.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>ESMO open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mosimann, F. Stella</au><au>Varano, V.</au><au>Tasca, G.</au><au>Girardi, F.</au><au>Tozzi, R.</au><au>Massa, D.</au><au>Zovato, S.</au><au>Saccardi, C.</au><au>Moserle, L.</au><au>Montagna, M.</au><au>Griguolo, G.</au><au>Guarneri, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors</atitle><jtitle>ESMO open</jtitle><date>2024-06</date><risdate>2024</risdate><volume>9</volume><spage>103564</spage><pages>103564-</pages><artnum>103564</artnum><issn>2059-7029</issn><eissn>2059-7029</eissn><pub>Elsevier Ltd</pub><doi>10.1016/j.esmoop.2024.103564</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2059-7029
ispartof ESMO open, 2024-06, Vol.9, p.103564, Article 103564
issn 2059-7029
2059-7029
language eng
recordid cdi_crossref_primary_10_1016_j_esmoop_2024_103564
source ScienceDirect®; PubMed Central
title 57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A22%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=57P%20Prognostic%20impact%20of%20functional%20domain%20of%20BRCA1/2%20mutation%20in%20platinum-sensitive%20recurrent%20epithelial%20ovarian%20cancer%20patients%20receiving%20PARP%20inhibitors&rft.jtitle=ESMO%20open&rft.au=Mosimann,%20F.%20Stella&rft.date=2024-06&rft.volume=9&rft.spage=103564&rft.pages=103564-&rft.artnum=103564&rft.issn=2059-7029&rft.eissn=2059-7029&rft_id=info:doi/10.1016/j.esmoop.2024.103564&rft_dat=%3Celsevier_cross%3ES2059702924013334%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1464-9ecda9430e88d1b5c9615358038a8be6823e27ab3f72be4603fcb579a8dcf7963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true